证券记录 · 已归档季度
AZN
AstraZeneca PLC · Healthcare · Drug Manufacturers - General
22被追踪持有人
-1Δ持有人
189.68M持有股份
$13.26B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -4.3% ·
股份流向 -4.1% ·
净新建仓位 -4.5%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 3.19M | $514.55M | n/a | −2 |
| Q2 2026 | 154 | +6 | 584.53M | $109.90B | +11 | −6 |
| Q1 2026 | 151 | +2 | 571.10M | $111.81B | +21 | −20 |
| Q4 2025 | 148 | 0 | 438.95M | $40.35B | +2 | −1 |
| Q3 2025 | 24 | 0 | 219.30M | $16.82B | +1 | −2 |
| Q2 2025 | 22 | -1 | 189.68M | $13.26B | n/a | −1 |
| Q1 2025 | 21 | 0 | 171.06M | $12.57B | n/a | n/a |
| Q4 2024 | 21 | +3 | 174.28M | $11.42B | +3 | n/a |
| Q3 2024 | 17 | -3 | 166.39M | $12.97B | n/a | −3 |
| Q2 2024 | 20 | n/a | 172.48M | $13.45B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 51.94M | -9.0% | $3.63B | 0.4% | ▼ Trim | 5 | SEC ↗ ×2 |
| 2 | PRIMECAP Management ✦ | 41.20M | +1.3% | $2.88B | 2.3% | ▲ Add | 5 | SEC ↗ |
| 3 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ ×8 |
| 4 | Fidelity (FMR) ✦ | 21.34M | n/a | $1.49B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 5 | Fisher Asset Management ✦ | 20.70M | +2.6% | $1.45B | 0.6% | ▲ Add | 5 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 5.49M | n/a | $383.47M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 7 | Marshall Wace ✦ | 2.00M | +45.3% | $139.76M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 1.90M | +12.2% | $133.12M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 1.83M | -10.5% | $127.95M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 10 | Point72 Asset Management ✦ | 1.69M | +41.9% | $117.79M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 1.30M | +335.8% | $91.11M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 1.16M | -67.8% | $80.75M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.14M | +20.3% | $79.97M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (被动) | 939.00K | -6.0% | $65.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 858.50K | +88.9% | $59.99M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 620.90K | -10.2% | $43.39M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 17 | Geode Capital Management ✦ (被动) | 505.06K | +2.9% | $35.29M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 325.39K | -49.7% | $22.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Capital World Investors ✦ | 153.56K | +2.8% | $10.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Dodge & Cox ✦ | 137.49K | +1.0% | $9.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Norges Bank ✦ (被动) | 60.38K | +268.6% | $4.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 53.94K | +43.9% | $3.77M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Soros Fund Management | $201.57M | 曾为 5.1% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,307 持有人, 729.50M 股份, $139.69B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 08
Sharma Mani
Officer · See Remarks · 20 股 @ 160.57 · $3,249
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据